Jane Macnaughtan
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Mitochondrial function is impaired in long COVID patients.
Journal: Annals of medicine
Published: August 12, 2025
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals.
Journal: Nature medicine
Published: June 16, 2025
Patient Plasma-Induced Neutrophil Dysfunction Is Associated With Infection Risk and Mortality in Patients With Acute Decompensation of Cirrhosis.
Journal: Alimentary pharmacology & therapeutics
Published: May 05, 2025
Severe GBA1 variants drive the GBA1-PD clinical phenotype: implications for counselling and clinical trials.
Journal: NPJ Parkinson's disease
Published: April 15, 2025
Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver disease.
Journal: JHEP reports : innovation in hepatology
Published: March 02, 2025
Alpha 2A adrenergic receptor antagonism reduces fibrosis, inflammation and portal hypertension in models of chronic liver disease.
Journal: JHEP reports : innovation in hepatology
Published: March 02, 2025
Exploring the relationship between GBA1 host genotype and gut microbiome in the GBA1 L444P/WT mouse model: implications for Parkinson's disease pathogenesis.
Journal: Frontiers in neuroscience
Published: December 16, 2024
Mediterranean Diet Adherence, Gut Microbiota and Parkinson's Disease: A Systematic Review.
Journal: Nutrients
Published: April 22, 2024
Evaluation of an Adapted Semi-Automated DNA Extraction for Human Salivary Shotgun Metagenomics.
Journal: Biomolecules
Published: August 29, 2023
α-Synuclein expression in response to bacterial ligands and metabolites in gut enteroendocrine cells: an in vitro proof of concept study.
Journal: Brain communications
Published: April 19, 2023
Last Updated: 09/26/2026